Your browser doesn't support javascript.
loading
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Monteith, Bethany E; Venner, Christopher P; Cheung, Matthew C; Pater, Joe; Shepherd, Lois; Richardson, Harriet; Reece, Donna; Gul, Engin; Lalancette, Marc; Castonguay, Vincent; Kukreti, Vishal; Tiedemann, Rodger; Phua, Chai; Bhella, Sita; Dudebout, Jill; Sherry, Max; Yen, Hope; Chen, Bingshu E; Hay, Annette E.
Affiliation
  • Monteith BE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Venner CP; Cancer Center of Southeastern Ontario, Queen's University, Kingston, ON, Canada.
  • Cheung MC; The Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Pater J; Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Shepherd L; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Richardson H; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Reece D; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Gul E; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Lalancette M; Canadian Myeloma Research Group (formerly the Myeloma Canada Research Network), Vaughan, ON, Canada.
  • Castonguay V; CHU de Québec, Hôtel-Dieu de Québec, Université Laval, Quebec City, QC, Canada.
  • Kukreti V; CHU de Québec, Hôtel-Dieu de Québec, Université Laval, Quebec City, QC, Canada.
  • Tiedemann R; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Phua C; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Bhella S; Victoria Hospital, Western University, London, ON, Canada.
  • Dudebout J; Cancer Center of Southeastern Ontario, Queen's University, Kingston, ON, Canada.
  • Sherry M; Cancer Center of Southeastern Ontario, Queen's University, Kingston, ON, Canada.
  • Yen H; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Chen BE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Hay AE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
Eur J Haematol ; 107(3): 333-342, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34053112
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Cost of Illness / Costs and Cost Analysis / Cyclophosphamide / Multiple Myeloma Type of study: Health_economic_evaluation / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Canada Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Cost of Illness / Costs and Cost Analysis / Cyclophosphamide / Multiple Myeloma Type of study: Health_economic_evaluation / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Canada Country of publication: United kingdom